Hilma Biocare CJC-1295 DAC 10 ml vial (2 mg)

CJC-1295

CJC-1295 is a synthesized form of a Growth Hormone-Releasing Hormone (GHRH) and a Growth Hormone Secretagogue (GHS). As a tetra-substituted peptide hormone composed of thirty amino acids, it offers a significant enhancement over GRF (1-29) due to its extended half-life.

This peptide notably elevates insulin-like growth factor 1 (IGF-1) and plasma growth hormone (GH) levels in both humans and animals. Research indicates that CJC-1295 can lead to increases in body weight, growth hormone levels, and total pituitary RNA, suggesting the creation of additional growth hormone-producing cells.

While both CJC-1295 (DAC) and CJC-1295 (GRF 1-29) are part of the same peptide class, the latter stimulates the body’s natural production of growth hormone. Notably, CJC-1295 maintains effectiveness in the bloodstream for up to two weeks.

Clinical studies reveal that the binding of CJC-1295 DAC to albumin and plasma proteins enhances its efficacy, further amplified by the lysine associated with the Drug Affinity Complex (DAC).

With a half-life of thirty minutes for GRF 1-29 and an impressive 6-8 days for CJC-1295 DAC, this product is ideally dosed bi-weekly. Results show that plasma growth hormone levels can spike by 2-10 times within six days post-injection, while IGF-1 concentrations may rise by 1.5-3 times within 9-11 days. Its effectiveness reflects a growth hormone dosage equivalent to 15 IU per day, providing substantial value.

Benefits of CJC-1295

Utilizing CJC-1295 DAC significantly enhances muscle growth conditions within the body. It accelerates the building of muscle mass while improving overall body strength and contributing to weight gains.

Research indicates the following benefits associated with CJC-1295 DAC:

• Enhanced body endurance and strength.
• Reduction of body fat, especially around the abdomen.
• Improved skin quality, promoting elasticity.
• Strengthened bone structure.
• Faster recovery from injuries and intense workouts.
• An appropriate dosage helps alleviate depression and fosters mental well-being.

Mechanism of Action

CJC-1295 DAC effectively prolongs its half-life, allowing benefits to persist for an extended duration post-injection. Users experience increased energy, strength, and endurance, enabling sustained productivity without fatigue.

With this peptide, the body experiences an urgent need for growth hormones and the myriad benefits associated with them.

Potential Side Effects

Possible negative side effects may encompass tingling, numbness, reduced insulin sensitivity, and fluid retention. Other reported side effects can include minor irritations, fatigue, headaches, and lethargy.

On a positive note, benefits such as rapid recovery, fat reduction, enhanced protein synthesis, increased lean body mass, improved bone density, and cellular stimulation for skin and organ health are commonly noted.

Storage Guidelines

Store in an airtight container at 2-8°C away from children. Avoid freezing.

Incompatibility Warnings

Avoid mixing CJC-1295 with other medical products and only reconstitute it using the provided solvent.

Dosage Recommendations

The initial dose loses efficacy by the fifth day; thus, it is recommended to administer CJC-1295 bi-weekly for optimal concentration. The advised dosage is 1000-2000 mcg twice weekly.

• Use Frequency: To maintain optimal concentration, inject 2 times a week, as effectiveness diminishes by day five, with a recommended dosage of 1000-2000 mcg.
• Injection Site: Administer into subcutaneous fat around the abdominal area.
• Dosage per Injection: 1000-2000 mcg (twice a week).